Paper18200041
Genetics of therapy-related myelodysplasia and acute myeloid leukemia.
Pedersen-Bjergaard J and 3 others. Leukemia, 2008. Cited by 173 papers, by iCite.
Cite this record
ConductScience Library. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Papers, record 18200041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18200041
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myeloid, Acute | Major topic |
| Mutation | Major topic |
| Myelodysplastic Syndromes | Major topic |
| Neoplasms, Second Primary | Major topic |
| Humans | |
| Signal Transduction | |
| Transcription Factors |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12970781 | Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. | Leukemia | 2003 | https://conductscience.org/library/papers/12970781 | PubMed |
| 2 | 16281072 | Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia. | Leukemia | 2005 | https://conductscience.org/library/papers/16281072 | PubMed |
| 3 | 12454741 | Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. | Leukemia | 2002 | https://conductscience.org/library/papers/12454741 | PubMed |
| 4 | 12194988 | Genetics of myeloid leukemias. | Annu Rev Genomics Hum Genet | 2002 | https://conductscience.org/library/papers/12194988 | PubMed |
| 5 | 3950675 | Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/3950675 | PubMed |
| 6 | 16051734 | Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. | Blood | 2005 | https://conductscience.org/library/papers/16051734 | PubMed |
| 7 | 16434492 | Implications of NRAS mutations in AML: a study of 2502 patients. | Blood | 2006 | https://conductscience.org/library/papers/16434492 | PubMed |
| 8 | 14615365 | High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. | Blood | 2004 | https://conductscience.org/library/papers/14615365 | PubMed |
| 9 | 9746770 | The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. | Blood | 1998 | https://conductscience.org/library/papers/9746770 | PubMed |
| 10 | 17159988 | Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. | Nat Med | 2007 | https://conductscience.org/library/papers/17159988 | PubMed |
| 11 | 7579462 | Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. | Blood | 1995 | https://conductscience.org/library/papers/7579462 | PubMed |
| 12 | 17910630 | RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. | Br J Haematol | 2007 | https://conductscience.org/library/papers/17910630 | PubMed |
| 13 | 15951308 | RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. | Blood | 2005 | https://conductscience.org/library/papers/15951308 | PubMed |
| 14 | 8943866 | Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. | Blood | 1996 | https://conductscience.org/library/papers/8943866 | PubMed |
| 15 | 14726504 | CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14726504 | PubMed |
| 16 | 16980411 | Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16980411 | PubMed |
| 17 | 16893685 | Chromatin structural elements and chromosomal translocations in leukemia. | DNA Repair (Amst) | 2006 | https://conductscience.org/library/papers/16893685 | PubMed |
| 18 | 16990778 | Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. | Leukemia | 2006 | https://conductscience.org/library/papers/16990778 | PubMed |
| 19 | 16467864 | Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. | Leukemia | 2006 | https://conductscience.org/library/papers/16467864 | PubMed |
| 20 | 9665199 | Establishment and characterization of a megakaryoblast cell line with amplification of MLL. | Leukemia | 1998 | https://conductscience.org/library/papers/9665199 | PubMed |
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42278263 | TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278263 | PubMed |
| 40227798 | Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40227798 | PubMed |
| 40138078 | Risk of secondary myeloid neoplasms following treatment in patients with grade I-II follicular lymphoma: a retrospective cohort study. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40138078 | PubMed |
| 40133836 | Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures. | BMC Genomics | 2025 | https://conductscience.org/library/papers/40133836 | PubMed |
| 39940930 | Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39940930 | PubMed |
| 39422544 | Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment. | Blood Cancer Discov | 2024 | https://conductscience.org/library/papers/39422544 | PubMed |
| 38541635 | Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38541635 | PubMed |
| 38178263 | Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy. | Biol Direct | 2024 | https://conductscience.org/library/papers/38178263 | PubMed |
| 37917833 | Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML. | Blood Cancer Discov | 2024 | https://conductscience.org/library/papers/37917833 | PubMed |
| 37847561 | A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37847561 | PubMed |
| 37088806 | Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. | Blood Cancer J | 2023 | https://conductscience.org/library/papers/37088806 | PubMed |
| 36980546 | Progress toward Better Treatment of Therapy-Related AML. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980546 | PubMed |
| 36696829 | Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms. | Leuk Res | 2023 | https://conductscience.org/library/papers/36696829 | PubMed |
| 36077220 | Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077220 | PubMed |
| 36040481 | Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis. | Ann Hematol | 2022 | https://conductscience.org/library/papers/36040481 | PubMed |
| 35740508 | CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35740508 | PubMed |
| 35615324 | De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences. | Mediterr J Hematol Infect Dis | 2022 | https://conductscience.org/library/papers/35615324 | PubMed |
| 35280084 | Myelodysplastic syndrome in a case of new-onset pancytopenia. | Clin Case Rep | 2022 | https://conductscience.org/library/papers/35280084 | PubMed |
| 34639121 | TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639121 | PubMed |
| 34428556 | Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. | Transplant Cell Ther | 2021 | https://conductscience.org/library/papers/34428556 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18200041
GET https://conductscience.org/api/papers/v1/18200041/references?page=2